SC 13G 1 dsc13g.htm SCHEDULE 13 G Schedule 13 G

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

(Amendment No.     )*

 

 

Sinovac Biotech Ltd.

(Name of Issuer)

Common stock, par value $0.001 per share

(Title of Class of Securities)

 

 

P8696W104

                                (CUSIP Number)                                

March 1, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. P8696W104   13G   Page 2 of 9 Pages

 

  1.  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Sanjay Motwani    
  2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*  
  (a)  ¨  
    (b)  ¨    
  3.   SEC USE ONLY  
         
  4.   CITIZENSHIP OR PLACE OF ORGANIZATION  
                United Kingdom    

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     5.    SOLE VOTING POWER
 
                  2,593,397 shares
    6.    SHARED VOTING POWER
 
                  —
    7.    SOLE DISPOSITIVE POWER
 
                  2,593,397 shares
    8.    SHARED DISPOSITIVE POWER
 
                  —
  9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                2,593,397 shares    
10.   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   ¨
         
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
                6.6%1    
12.   TYPE OF REPORTING PERSON  
                IN, HC    

 

1 Based on the number of Sinovac Biotech Ltd. common shares outstanding as reported in Sinovac Biotech Ltd.’s Form 20-F filed with the Securities and Exchange Commission on July 14, 2006. The reporting person beneficially owned 2,593,397 shares of common stock of Sinovac Biotech Ltd. as of March 9, 2007.

 

Page 2 of 9 Pages

CUSIP No. P8696W104   13G   Page 3 of 9 Pages

 

  1.  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Sansar Family II, L.L.C.    
  2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*  
  (a)  ¨  
    (b)  ¨    
  3.   SEC USE ONLY  
         
  4.   CITIZENSHIP OR PLACE OF ORGANIZATION  
                Delaware    

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     5.    SOLE VOTING POWER
 
                  2,593,397 shares
    6.    SHARED VOTING POWER
 
                  —
    7.    SOLE DISPOSITIVE POWER
 
                  2,593,397 shares
    8.    SHARED DISPOSITIVE POWER
 
                  —
  9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                2,593,397 shares    
10.   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   ¨
         
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
                6.6%2    
12.   TYPE OF REPORTING PERSON  
                CO, HC    

 

2 Based on the number of Sinovac Biotech Ltd. common shares outstanding as reported in Sinovac Biotech Ltd.’s Form 20-F filed with the Securities and Exchange Commission on July 14, 2006. The reporting person beneficially owned 2,593,397 shares of common stock of Sinovac Biotech Ltd. as of March 9, 2007.

 

Page 3 of 9 Pages

CUSIP No. P8696W104   13G   Page 4 of 9 Pages

 

  1.  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Sansar Capital Management, L.L.C.    
  2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*  
  (a)  ¨  
    (b)  ¨    
  3.   SEC USE ONLY  
         
  4.   CITIZENSHIP OR PLACE OF ORGANIZATION  
                Delaware    

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     5.    SOLE VOTING POWER
 
                  2,593,397 shares
    6.    SHARED VOTING POWER
 
                  —
    7.    SOLE DISPOSITIVE POWER
 
                  2,593,397 shares
    8.    SHARED DISPOSITIVE POWER
 
                  —
  9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                2,593,397 shares    
10.   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   ¨
         
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
                6.6%3    
12.   TYPE OF REPORTING PERSON  
                OO    

 

3 Based on the number of Sinovac Biotech Ltd. common shares outstanding as reported in Sinovac Biotech Ltd.’s Form 20-F filed with the Securities and Exchange Commission on July 14, 2006. The reporting person beneficially owned 2,593,397 shares of common stock of Sinovac Biotech Ltd. as of March 9, 2007.

 

Page 4 of 9 Pages

SCHEDULE 13G
Item 1  

(a)

    Name of Issuer:      
     Sinovac Biotech Ltd.      

        1

  

(b)

    Address of Issuer’s Principal Executive Offices:      
    

39 Shangdi Xi Road

Haidan District

Beijing F4 100085

      
Item 2  

(a)

    Name of Person Filing:      
     Sanjay Motwani is the managing member of Sansar Family II, L.L.C., which is the managing member of Sansar Capital Management, L.L.C. All of the shares of common stock that were beneficially owned by the reporting persons were held by a fund to which Sansar Capital Management, L.L.C. acts as an investment advisor.      

        2

  

(b)

    Address of Principal Business Office or, if none, Residence:      
     The principal business address of each of Sanjay Motwani, Sansar Family II, L.L.C. and Sansar Capital Management, L.L.C. is 25 West 53rd Street, New York, NY 10019.      

        2

  

(c)

    Citizenship:      
     Sanjay Motwani is a United Kingdom citizen. Sansar Family II, L.L.C. is a Delaware limited liability company. Sansar Capital Management, L.L.C. is a Delaware limited liability company.      

        2

  

(d)

    Title of Class of Securities:      
    

Common stock, par value $0.001 per share

      

        2

  

(e)

    CUSIP Number:      
     P8696W104      
Item 3   This statement is filed pursuant to Rule 13d-1(c).   

 

Page 5 of 9 Pages

Item 4    Ownership:      
   With respect to the beneficial ownership of shares of common stock of Sinovac Biotech Ltd. by the reporting persons, see Items 5 through 11 of the cover pages of this Schedule 13G, which are incorporated herein by reference.      
Item 5    Ownership of Five Percent or Less of a Class:   
   Not Applicable.   
Item 6    Ownership of More than Five Percent on Behalf of Another Person:      
   Not Applicable.      
Item 7    Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company:
   Not Applicable.
Item 8    Identification and Classification of Members of the Group:      
   Not Applicable.      
Item 9    Notice of Dissolution of Group:      
   Not Applicable.      
Item 10    Certification:      
  

By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

The reporting persons have agreed that this Schedule 13G may be filed by Sanjay Motwani on behalf of all of them jointly pursuant to Rule 13d-1(k)(1). A copy of such agreement is attached as an Exhibit to this Schedule 13G.

      

 

Page 6 of 9 Pages

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

/s/ Sanjay Motwani

 

Sanjay Motwani

March 12, 2007

 

Page 7 of 9 Pages

EXHIBIT INDEX

Exhibit I - Agreement Regarding the Joint Filing of Schedule 13G

 

Page 8 of 9 Pages

Exhibit I

AGREEMENT REGARDING

THE JOINT FILING OF SCHEDULE 13G

The undersigned hereby agree as follows:

 

  (i) Each of them is individually eligible to use the Schedule 13G to which this Exhibit is attached, and such Schedule 13G is filed on behalf of each of them; and

 

  (ii) Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

Dated: March 12, 2007

 

SANJAY MOTWANI

/s/ Sanjay Motwani

Sanjay Motwani
SANSAR FAMILY II, L.L.C.
By:  

/s/ Sanjay Motwani

  Sanjay Motwani
  Managing Member
SANSAR CAPITAL MANAGEMENT, L.L.C.
By:  

Sansar Family II, L.L.C.,

  its Managing Member
By:  

/s/ Sanjay Motwani

  Sanjay Motwani
  Managing Member

 

Page 9 of 9 Pages